Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the 44th annual J.P. Morgan healthcare conference on Monday, January 12, 2026.
MedPage Today on MSN
FDA Flags Medtronic Recall as Most Serious; Hep B Cure? Appendectomy for UC
The FDA designated the recall of certain Medtronic Bravo esophageal pH monitoring capsules as class I, the most serious type.
Medtronic disclosed Diabetes unit executive pay packages for 2025 and compensation targets for when they'll lead MiniMed as a ...
Supermodel Bambi Northwood-Blyth wears a Dexcom glucose monitor. So does your next-door neighbor with Type 2 diabetes and ...
11h
Pulse Oximeters Market at the Heart of Remote Care: A USD 6.76 Billion Growth Opportunity by 2034
The global pulse oximeter market size was valued at USD 3.56 billion in 2024 and is predicted to hit around USD 6.76 billion by 2034, rising at a 6.64% CAGR, a study published by Towards Healthcare a ...
Wearable health devices may soon operate under looser regulatory oversight following new guidance from the FDA ...
It has issued new guidance to clarify its regulatory approach on wearable devices. Read more at straitstimes.com. Read more ...
The global diabetes injection pens market is projected to grow at a CAGR of approximately 7% through 2028. Market expansion ...
These technologies are improving all the time. If they’re not making claims that they are medical grade, let’s let the market ...
The global Surgical Retractors Market is projected to grow at a CAGR of approximately 6–7% during the forecast period. Market ...
FDA plans limited regulation of wearable medical devices, boosting Apple, Fitbit, Oura stocks as 50% of Americans use fitness ...
Background Emergency Medical Services (EMS) patients with chest pain are often suspected of having non-ST-elevation acute coronary syndrome (NSTE-ACS). Current risk stratification protocols for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback